139 related articles for article (PubMed ID: 1888684)
21. [Clinical usefulness of pharmacological treatment of Cushing's syndrome].
Saito J; Nishikawa T
Nihon Rinsho; 1994 Mar; 52(3):793-6. PubMed ID: 8164384
[TBL] [Abstract][Full Text] [Related]
22. [Non-invasive therapy of Cushing's syndrome].
Miura K
Nihon Naika Gakkai Zasshi; 1994 Sep; 83(9):1627-32. PubMed ID: 7798761
[No Abstract] [Full Text] [Related]
23. Therapeutic possibilities in Cushing's syndrome.
Melby JC
N Engl J Med; 1971 Jul; 285(5):288-9. PubMed ID: 4326258
[No Abstract] [Full Text] [Related]
24. [Preliminary results of treatment of hypercorticism with aminoglutethimide].
Chen JL
Zhonghua Nei Ke Za Zhi; 1982 Dec; 21(12):747-9, 777-8. PubMed ID: 7182138
[No Abstract] [Full Text] [Related]
25. Cushing's disease in a patient with a 'nonfunctioning' pituitary tumor. Spontaneous development and remission.
Gogel EL; Salber PR; Tyrrell JB; Rosenblum ML; Findling JW
Arch Intern Med; 1983 May; 143(5):1040-2. PubMed ID: 6089681
[TBL] [Abstract][Full Text] [Related]
26. Recurrent ACTH-independent Cushing's syndrome in multiple pregnancies and its treatment with metyrapone.
Hána V; Dokoupilová M; Marek J; Plavka R
Clin Endocrinol (Oxf); 2001 Feb; 54(2):277-81. PubMed ID: 11207645
[TBL] [Abstract][Full Text] [Related]
27. Treatment of Cushing's disease with adrenal blocking drugs and megavoltage therapy to the pituitary.
Ross WM; Evered DC; Hunter P; Benaim M; Cook D; Hall R
Clin Radiol; 1979 Mar; 30(2):149-53. PubMed ID: 219982
[TBL] [Abstract][Full Text] [Related]
28. Is pseudo-Cushing's syndrome in a critically ill patient "pseudo"? Hypothesis and supportive case report.
Kem DC; Metcalf JP; Cornea A; Dunnam M; Engelbrecht A; Yu X
Endocr Pract; 2007; 13(2):153-8. PubMed ID: 17490929
[TBL] [Abstract][Full Text] [Related]
29. Prolonged remission in florid Cushing's syndrome following metyrapone treatment.
Beardwell CG; Adamson AR; Shalet SM
Clin Endocrinol (Oxf); 1981 May; 14(5):485-92. PubMed ID: 6273022
[TBL] [Abstract][Full Text] [Related]
30. Suppression of tumorous adrenal hyperfunction by aminoglutethimide.
Smilo RP; Earll JM; Forsham PH
Metabolism; 1967 Apr; 16(4):374-7. PubMed ID: 4290376
[No Abstract] [Full Text] [Related]
31. [The effect of aminoglutethimide in the treatment of adrenal gland hyperfunction].
Neumann P; Knappe G; Stahl F; Kublun G; Bruns W; Wulfert P
Z Gesamte Inn Med; 1979 May; 34(9):247-53. PubMed ID: 225896
[No Abstract] [Full Text] [Related]
32. [Cushing's disease and hypercorticism: clinical, biologic and physiopathologic considerations].
Boyer J
Mars Med; 1968; 105(3):281-5. PubMed ID: 5739897
[No Abstract] [Full Text] [Related]
33. Results of treatment in 108 patients with Cushing's syndrome.
Orth DN; Liddle GW
N Engl J Med; 1971 Jul; 285(5):243-7. PubMed ID: 4326256
[No Abstract] [Full Text] [Related]
34. Preoperative management of Cushing's syndrome with metyrapone for severe psychiatric disturbances.
Obinata D; Yamaguchi K; Hirano D; Yoshida T; Soma M; Takahashi S
Int J Urol; 2008 Apr; 15(4):361-2. PubMed ID: 18380829
[TBL] [Abstract][Full Text] [Related]
35. [Present knowledge on the treatment of Cushing's syndrome].
Bricaire H; Albeaux-Fernet M; Lumbroso P; Netter A; Sebaoun J
Presse Med (1893); 1969 Nov; 77(46):1665-8. PubMed ID: 5380390
[No Abstract] [Full Text] [Related]
36. [Treatment with metyrapone of Cushing's syndrome revealing McCune-Albright syndrome].
Halioui-Louhaichi S; Azzabi O; Nefzi L; Ben Hariz M; Ben Mrad N; Ben Ammar B; Maherzi A
Arch Pediatr; 2005 Jul; 12(7):1120-3. PubMed ID: 15964528
[TBL] [Abstract][Full Text] [Related]
37. [Considerations of the advent and evolution of climacteric during Cushing's disease and secondary hypercorticism].
Augustin M; Manciulesco D
Rev Fr Endocrinol Clin; 1969; 10(2):99-108. PubMed ID: 5807413
[No Abstract] [Full Text] [Related]
38. Effects of aminoglutethimide upon adrenal function and cortisol metabolism in Cushing's syndrome.
Schteingart DE; Conn JW
J Clin Endocrinol Metab; 1967 Dec; 27(12):1657-66. PubMed ID: 6060954
[No Abstract] [Full Text] [Related]
39. The immunological hazard of Cushing's syndrome.
Britton S; Thorén M; Sjoberg HE
Br Med J; 1975 Dec; 4(5998):678-80. PubMed ID: 1081900
[TBL] [Abstract][Full Text] [Related]
40. Primary therapy for Cushing's disease with metyrapone.
Dickstein G; Lahav M; Shen-Orr Z; Edoute Y; Barzilai D
JAMA; 1986 Mar; 255(9):1167-9. PubMed ID: 3003415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
